International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

Respiratory disease in minority groups

Symposium
Chairs: Bo Lundback (Gothenburg, Sweden), Giovanni Viegi (Pisa, Italy)
Aims: To describe the differences between ethnic minority groups in terms of respiratory disease prevalence, provide plausible genetic and environmental explanations for such prevalence differences, describe the current challenges faced by Europe in terms of providing healthcare to ethnic minority groups and review the academic argument about how we should assess 'normal' lung function in ethnic minority groups.
Target audience: Clinicians, healthcare professionals, and epidemiologists.

Download all media

Health in ethnic minority groups in Europe: what are the current challenges? Aziz Sheikh (Edinburgh, United Kingdom)
Respiratory disease and ethnicity: the US Experience R. Graham Barr (New York, United States of America)
What is the evidence that ethnic differences in the prevalence of respiratory disease are explained by differences in genetic make-up? H. Marike Boezen (Groningen, Netherlands)
COPD and ethnicity Peter Burney (London, United Kingdom)